SMS Pharmaceuticals IPO
SMS Pharmaceuticals IPO — date, price band, lot size & details 2007
SMS Pharmaceuticals listed on 28 Feb 2007 at ₹360, 5.3% below the ₹380 issue price.
SMS Pharmaceuticals is an Andhra Pradesh based maker of active pharmaceutical ingredients and intermediates such as Ranitidine, Sumatriptan and Sildenafil. Its standalone net worth was Rs 617.82 million on 30 September 2006.
Stock price
SMS Pharmaceuticals is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 05 Feb 2007
- Close 08 Feb 2007
- Allotment TBA
- Refund/credit TBA
- Listing 28 Feb 2007
Issue summary
The terms of the offer, as filed.
| IPO Dates | 5 to 8 Feb, 2007 |
|---|---|
| Price Band | ₹360 – ₹380 |
| Face Value | ₹10 |
| Lot Size | 15 Shares |
| Issue Size | ₹98.01 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | Aarthi Consultants Pvt.Ltd. |
| Min Investment | ₹ 5,700 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 15 shares at the ₹380 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 15 | ₹5,700 |
| Retail (max) | 35 | 525 | ₹1,99,500 |
| S-HNI (min) | 36 | 540 | ₹2,05,200 |
| S-HNI (max) | 175 | 2,625 | ₹9,97,500 |
| B-HNI (min) | 176 | 2,640 | ₹10,03,200 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01It had an installed capacity of approximately 1440 MTPA.
- 02It made at least 8 named bulk drugs and their intermediates.
- 03Standalone net worth rose from Rs 488.52 million in March 2006 to Rs 617.82 million in September 2006.
- 04Return on net worth was 17.41%.
Risks · 5
- 01190 of its 625 workers were on daily wages and 105 on contract.
- 02Bulk drug prices are competitive across its 8 named products, and buyers can switch suppliers.
- 03A fact finding committee of the Andhra Pradesh High Court had inspected industrial units in its area following a writ petition; it had 625 workers.
- 04Chemical plants face pollution rules and approvals for changes to its 1440 MTPA capacity.
- 05Promoter holding fell from 72.31% before the issue to 53.68% after it.
Three years of numbers
All figures in ₹ crore, as reported in the SMS Pharmaceuticals offer document.
| Metric | 30 Sep 2006 | 31 Mar 2006 | 31 Mar 2005 | 31 Mar 2004 |
|---|---|---|---|---|
| Total Income | 97.63 | 133.48 | 121.20 | 118.35 |
| Profit After Tax | 10.60 | 8.51 | 8.26 | 7.22 |
| NET Worth | 61.78 | 48.85 | 41.76 | 35.89 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the SMS Pharmaceuticals RHP.
Where the money goes
₹113.02 Cr of the issue is earmarked to named objects.
About the company
Its bulk drugs included Ranitidine HCl, Sumatriptan Succinate, Sildenafil Citrate, Omeprazole Magnesium, Ramipril, Almotriptan, Gemcitabine and Imatinib Mesilate and their intermediates. It also did contract research with SPECS of the Netherlands.
It had an installed capacity of approximately 1440 MTPA and 625 employees as on 30 November 2006, of whom 330 were permanent.
The IPO was Rs 98.01 crore and was entirely a fresh issue at Rs 380, the top of the Rs 360 to Rs 380 band.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
040-27638111/27638111/27638111
The bankers & the filings
Who is running the book, and the documents this page is built from.
SMS Pharmaceuticals IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Standard Chartered Securities (India) Ltd
24 issues handledBest listing: Vivimed Labs (+87.1%). Weakest: Abhishek Mills (-14.9%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of SMS Pharmaceuticals?
The current Grey Market Premium is ₹0.
What is the SMS Pharmaceuticals IPO price band?
₹360 to ₹380, on a face value of ₹10.
When is the allotment?
The basis of allotment is TBA, with listing on 28 February 2007.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — Aarthi Consultants Pvt.Ltd..
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
